PAH and phenylketonuria: In this sense, the created avatar PKU mouse model with the humanized mutant (c.1066-11A) intron 10 fragment of the endogenous Pah gene is a suitable preclinical model for assessing the efficacy of adenine base editing as a therapeutic intervention, which could be applicable to a high number of PKU patients worldwide.